Sample Processing and Production Labs
The home of earlier cancer detection
As a global leader in biotechnology and molecular diagnostics, Exact Sciences utilizes advanced science, a rigorous process, and an open-minded approach to develop life-changing innovations in earlier colon cancer detection and treatment options. Their groundbreaking research and pioneering pipeline efforts have led to a robust scientific platform of proprietary technology, including the company's flagship precancer and cancer screening test, Cologuard.
To support their continued growth, industry innovations, and overarching mission to save lives, Exact Sciences partnered with a select team of local firms to analyze their existing site locations and develop a comprehensive, facility-wide improvement strategy. As part of these efforts, Flad provided interior architectural services and laboratory programming and planning for a major expansion effort at the Discovery Campus.
Comprised of two buildings – a state-of-the-art clinical laboratory and cGMP production laboratory/manufacturing facility – Exact Sciences' expanded Discovery Campus provides capacity to process up to seven million Cologuard tests per year. Flad programmed and planned nearly 60,000 square feet of clinical laboratory space in building one, which supports specimen processing, DNA capture, molecular processing, amplification, and equipment training. The 59,000-square-foot cGMP production laboratory supports manufacturing and processing, as well as filling, kitting, quality control, and tech transfer functions.
As an organization dedicated to continuous process improvement, a key highlight of the project included extensive analysis of process flows to evaluate personnel, samples, materials, and waste movement within the building. As a result of this analysis, the design team was able to provide flexibility that allowed Exact Sciences to seamlessly incorporate improvement initiatives – including automation, equipment upgrades, and expansion opportunities – that maximize operational efficiency, enhance overall productivity, and increase safety.
In a time when more than 30 million Americans are not current with colorectal cancer screening, these laboratories serve as a milestone in advancing modern healthcare. Exact Sciences CEO, Kevin Conroy, states, "From this campus, our Laboratory and Customer Care teams will help people across the country get screened and detect colorectal cancers and precancers. This will help improve outcomes, change lives, and reduce the toll colorectal cancer takes on our society."
Project TypeScience & Technology